Unknown

Dataset Information

0

Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse.


ABSTRACT: DNA methylation of CpG islands around gene transcription start sites results in gene silencing and plays a role in leukemia pathophysiology. Its impact in leukemia progression is not fully understood. We performed genomewide screening for methylated CpG islands and identified 8 genes frequently methylated in leukemia cell lines and in patients with acute myeloid leukemia (AML): NOR1, CDH13, p15, NPM2, OLIG2, PGR, HIN1, and SLC26A4. We assessed the methylation status of these genes and of the repetitive element LINE-1 in 30 patients with AML, both at diagnosis and relapse. Abnormal methylation was found in 23% to 83% of patients at diagnosis and in 47% to 93% at relapse, with CDH13 being the most frequently methylated. We observed concordance in methylation of several genes, confirming the presence of a hypermethylator pathway in AML. DNA methylation levels increased at relapse in 25 of 30 (83%) patients with AML. These changes represent much larger epigenetic dysregulation, since methylation microarray analysis of 9008 autosomal genes in 4 patients showed hypermethylation ranging from 5.9% to 13.6% (median 8.3%) genes at diagnosis and 8.0% to 15.2% (median 10.6%) genes in relapse (P < .001). Our data suggest that DNA methylation is involved in AML progression and provide a rationale for the use of epigenetic agents in remission maintenance.

SUBMITTER: Kroeger H 

PROVIDER: S-EPMC2515110 | biostudies-literature | 2008 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


DNA methylation of CpG islands around gene transcription start sites results in gene silencing and plays a role in leukemia pathophysiology. Its impact in leukemia progression is not fully understood. We performed genomewide screening for methylated CpG islands and identified 8 genes frequently methylated in leukemia cell lines and in patients with acute myeloid leukemia (AML): NOR1, CDH13, p15, NPM2, OLIG2, PGR, HIN1, and SLC26A4. We assessed the methylation status of these genes and of the rep  ...[more]

Similar Datasets

| S-EPMC218745 | biostudies-literature
| S-EPMC6770227 | biostudies-literature
| S-EPMC4062060 | biostudies-literature
| S-EPMC5641248 | biostudies-literature
| S-EPMC5488578 | biostudies-other
| S-EPMC7271605 | biostudies-literature
| S-EPMC3217177 | biostudies-literature
| S-EPMC2653261 | biostudies-literature
| S-EPMC6335405 | biostudies-other
| S-EPMC5537054 | biostudies-literature